Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system

被引:147
作者
Kogure, Kentaro [1 ]
Akita, Hidetaka [1 ]
Yamada, Yuma [1 ]
Harashima, Hideyoshi [1 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Sapporo, Hokkaido 0600812, Japan
关键词
octaarginine; gene delivery; nanoparticle; membrane fusion; nuclear deposition; multifunctional; nano device; Programmed packaging; MEND; siRNA;
D O I
10.1016/j.addr.2007.10.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this review, we describe a key role of octaarginine (R8) in developing our new concept of "Programmed Packaging", by which we succeeded in creating a multifunctional envelope-type nano device (MEND) as a non-viral gene-delivery system. This concept can be applied not only to nuclear targeting of plasmid DNA (pDNA) but also to cytosolic delivery of functional nucleic acids such as oligonucleotides or siRNA, This concept has been extended to other organelles such as mitochondria as a foundation for innovative nanomedicine. Finally, we discuss the rate-limiting step in gene delivery by comparing non-viral and viral gene delivery systems, which clearly indicates the importance of nuclear disposition of pDNA for efficient transfection. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:559 / 571
页数:13
相关论文
共 53 条
[1]   Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy [J].
Akita, H ;
Ito, R ;
Khalil, IA ;
Futaki, S ;
Harashima, H .
MOLECULAR THERAPY, 2004, 9 (03) :443-451
[2]   Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors [J].
Al-Taei, S ;
Penning, NA ;
Simpson, JC ;
Futaki, S ;
Takeuchi, T ;
Nakase, I ;
Jones, AT .
BIOCONJUGATE CHEMISTRY, 2006, 17 (01) :90-100
[3]   SEQUENCE AND ORGANIZATION OF THE HUMAN MITOCHONDRIAL GENOME [J].
ANDERSON, S ;
BANKIER, AT ;
BARRELL, BG ;
DEBRUIJN, MHL ;
COULSON, AR ;
DROUIN, J ;
EPERON, IC ;
NIERLICH, DP ;
ROE, BA ;
SANGER, F ;
SCHREIER, PH ;
SMITH, AJH ;
STADEN, R ;
YOUNG, IG .
NATURE, 1981, 290 (5806) :457-465
[4]   Zonal necrosis prevented by transduction of the artificial anti-death FNK protein [J].
Asoh, S ;
Mori, T ;
Nagal, S ;
Yamagata, K ;
Nishimaki, K ;
Miyato, Y ;
Shidara, Y ;
Ohta, S .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (04) :384-394
[5]   Protection against ischemic brain injury by protein therapeutics [J].
Asoh, S ;
Ohsawa, I ;
Mori, T ;
Hiraide, T ;
Katayama, Y ;
Kimura, M ;
Ozaki, D ;
Yamagata, K ;
Ohta, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (26) :17107-17112
[6]   Mitochondria: Dynamic organelles in disease, aging, and development [J].
Chan, David C. .
CELL, 2006, 125 (07) :1241-1252
[7]   Targeting proteins to mitochondria using TAT [J].
Del Gaizo, V ;
MacKenzie, JA ;
Payne, RM .
MOLECULAR GENETICS AND METABOLISM, 2003, 80 (1-2) :170-180
[8]   A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta [J].
Del Gaizo, V ;
Payne, RM .
MOLECULAR THERAPY, 2003, 7 (06) :720-730
[9]   Evolution of the molecular machines for protein import into mitochondria [J].
Dolezal, Pavel ;
Likic, Vladimir ;
Tachezy, Jan ;
Lithgow, Trevor .
SCIENCE, 2006, 313 (5785) :314-318
[10]   NUCLEAR GENES ENCODING MITOCHONDRIAL PROTEINS IN YEAST [J].
DOUGLAS, M ;
TAKEDA, M .
TRENDS IN BIOCHEMICAL SCIENCES, 1985, 10 (05) :192-194